BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 17273885)

  • 21. Longitudinal splitting of optic pathways by non-functioning pituitary macroadenoma: report of two cases.
    Gagliardi F; Boari N; Losa M; Mortini P
    Acta Neurochir (Wien); 2010 Jun; 152(6):1065-8; discussion 1068. PubMed ID: 19826754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinotopic organization of the visual cortex before and after decompression of the optic chiasm in a patient with pituitary macroadenoma.
    Chouinard PA; Striemer CL; Ryu WH; Sperandio I; Goodale MA; Nicolle DA; Rotenberg B; Duggal N
    J Neurosurg; 2012 Aug; 117(2):218-24. PubMed ID: 22680245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chiasmal compression due to obstructive hydrocephalus.
    Bogdanovic MD; Plant GT
    J Neuroophthalmol; 2000 Dec; 20(4):266-7. PubMed ID: 11130755
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
    Monteiro ML; Zambon BK; Cunha LP
    Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual prognosis in pituitary tumors.
    Jain IS; Gupta A; Khurana GS; Khosla VK
    Ann Ophthalmol; 1985 Jul; 17(7):392-6. PubMed ID: 4037598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical management of chiasmal compression.
    Walsh LS
    Proc R Soc Med; 1977 May; 70(5):317-9. PubMed ID: 877096
    [No Abstract]   [Full Text] [Related]  

  • 27. Visual field improvement after pituitary tumor surgery in patients with McCune-Albright syndrome.
    Ma J; Zhao C; Wang R; Feng F; Wang E; You H; Jiang Y; Zhang M; Zhong Y
    J Neuroophthalmol; 2013 Mar; 33(1):26-9. PubMed ID: 23222370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual outcome after endoscopic decompression surgery for sphenoid sinus disease: how we do it.
    Yoon TM; Kim K; Lim SC
    Clin Otolaryngol; 2008 Oct; 33(5):480-4. PubMed ID: 18983386
    [No Abstract]   [Full Text] [Related]  

  • 29. Humphrey Matrix perimetry in optic nerve and chiasmal disorders: comparison with Humphrey SITA standard 24-2.
    Huang CQ; Carolan J; Redline D; Taravati P; Woodward KR; Johnson CA; Wall M; Keltner JL
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):917-23. PubMed ID: 18326712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Compression lesions of the chiasmal area from the viewpoint of the ophthalmologist].
    Lesták J; Vladyková J; Houst'ava L
    Cesk Slov Oftalmol; 1995 Jul; 51(3):165-70. PubMed ID: 7656352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visual outcomes of pituitary adenoma surgery. St. Vincent's Hospital 1968-1987.
    Sullivan LJ; O'Day J; McNeill P
    J Clin Neuroophthalmol; 1991 Dec; 11(4):262-7. PubMed ID: 1838546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of the multifocal visual evoked potential and standard automated perimetry in compressive optic neuropathies.
    Danesh-Meyer HV; Carroll SC; Gaskin BJ; Gao A; Gamble GD
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1458-63. PubMed ID: 16565379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
    Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
    World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuro-ophthalmological alternations in patients with pituitary adenomas and intrasellar arachnoidocele].
    Cáceres M; Márquez M; Sánchez-Ramos M
    Rev Neurol; 1998 Jun; 26(154):954-6. PubMed ID: 9658466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early morphological recovery of the optic chiasm is associated with excellent visual outcome in patients with compressive chiasmal syndrome caused by pituitary tumors.
    Yoneoka Y; Hatase T; Watanabe N; Jinguji S; Okada M; Takagi M; Fujii Y
    Neurol Res; 2015 Jan; 37(1):1-8. PubMed ID: 24938320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vision-related quality of life in patients with pituitary adenoma.
    Okamoto Y; Okamoto F; Hiraoka T; Yamada S; Oshika T
    Am J Ophthalmol; 2008 Aug; 146(2):318-322. PubMed ID: 18538298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Surgical treatment for giant pituitary adenomas: the state of visual functions].
    Kadashev BA; Faĭzullaev RB; Kalinin PL; Kutin MA; Shkarubo AN; Alekseev SN; Fomichev DV; Grigor'eva NN; Tropinskaia OF
    Vestn Oftalmol; 2009; 125(2):7-10. PubMed ID: 19517822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy.
    Lee S; Kim SJ; Yu YS; Kim YH; Paek SH; Kim DG; Jung HW
    Br J Neurosurg; 2013 Aug; 27(4):425-9. PubMed ID: 23421587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Why fatheads just don't see.
    Kosmorsky GS; Straga JM
    J Neuroophthalmol; 1997 Jun; 17(2):124-6. PubMed ID: 9176784
    [No Abstract]   [Full Text] [Related]  

  • 40. Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma.
    Gedik S; Gur S; Atalay B; Colak M; Altinors N; Akova YA
    Saudi Med J; 2007 Sep; 28(9):1380-4. PubMed ID: 17768464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.